Glucomannan-Magnesium Hydrogen Sustaining Composition

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating and sustaining molecular hydrogen in aqueous solutions are inefficient, requiring purified water and resulting in low output and short-lived hydrogen presence, which limits its therapeutic efficacy for health benefits.

Innovation Solution

A method involving the combination of glucomannan and magnesium metal powder in an aqueous solvent, generating and retaining molecular hydrogen through electrolysis or reaction with water, creating a gel or liquid solution that maintains high hydrogen concentrations for extended periods.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Duration of action of moving object

If molecular hydrogen is generated in aqueous solutions using conventional methods, then hydrogen can be produced, but the hydrogen presence is short-lived and therapeutic efficacy is limited

Engineering Contradiction:
Improveduration of molecular hydrogen presenceVSAvoidtherapeutic efficacy
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

Glucomannan acts as an intermediary substance that stabilizes and extends the presence of molecular hydrogen in aqueous solutions. The glucomannan polymer creates a protective environment that prevents rapid diffusion and degradation of H2, thereby extending its duration of action while maintaining therapeutic concentrations

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The invention creates a composite system combining glucomannan polymer with molecular hydrogen in aqueous solution. This composite formulation enhances the stability and persistence of hydrogen compared to conventional pure water-based systems, directly addressing the short-lived nature of H2

Inventive Principle:
Principle #40Composite materials

2Productivity

If purified water is used for generating molecular hydrogen, then the solution is clean, but the hydrogen output is low and efficiency is reduced

Engineering Contradiction:
Improvehydrogen outputVSAvoidamount of purified water required
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The invention changes the physical-chemical parameters of the aqueous solution by adding glucomannan polymer, which alters the solution's viscosity, surface tension, and molecular interaction properties. These parameter changes enable enhanced hydrogen generation efficiency and extended H2 persistence without requiring large volumes of purified water

Inventive Principle:
Principle #35Parameter changes

3Duration of action of moving object

If molecular hydrogen is administered to humans and animals, then health benefits are achieved, but the duration in tissues is short-lived

Engineering Contradiction:
Improveduration of H2 in tissuesVSAvoidtherapeutic efficacy
Core Design Contradiction:
Duration of action of moving objectVSProductivity

Solution Approach 1:

Glucomannan serves as a carrier intermediary that facilitates sustained delivery of molecular hydrogen to tissues. The polymer matrix maintains hydrogen reservoirs that continuously supply H2 to tissues over extended periods, overcoming the rapid diffusion limitation of free hydrogen

Inventive Principle:
Principle #24Intermediary (Mediator)

Solution Approach 2:

The glucomannan-hydrogen complex is prepared in advance with optimized hydrogen saturation levels. This preliminary preparation ensures that the formulation contains sufficient dissolved and microbubble-associated hydrogen to maintain therapeutic concentrations in tissues throughout the extended duration of action

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The glucomannan-magnesium metal powder solution effectively sustains molecular hydrogen levels, allowing for prolonged therapeutic benefits, including anti-aging and disease prevention, by maintaining concentrations up to 70% of the initial level for several days.

Implementation Method 1

adding from about 0.00001% w/v to about 7.5% w/v glucomannan and about 0.005% to about 2.0% w/v magnesium metal powder to the aqueous solvent

Methodology Applied
Scientific EffectHydrolysis: Hydrolysis

Implementation Method 2

the generated glucomannan solution comprises an initial H2 concentration of greater than about 100 ppb (parts per billion); and wherein, upon exposure of the glucomannan solution to standard temperature and pressure (STP) for 240 minutes after its generation, the glucomannan solution comprises an H2 concentration at least about 50% or at least about 70% of the initial H2 concentration

Methodology Applied
Scientific EffectAbsorption (physical): Absorption (physical)

Data Source

PatentUS12128065B2Composition and methods for generating and sustaining molecular hydrogen (H<sub>2</sub>) in aqueous systems
Publication Date: 2024.10.29 AZULENT LLC
  • US12128065B2 patent drawing
  • US12128065B2 patent drawing
  • US12128065B2 patent drawing

AI summary

Provided are compositions, methods, and solutions for generating aqueous glucomannan solutions with hydrogen compositions greater than 100 parts per billion. Said glucomannan solutions have application in nutritional, therapeutic, and energy fields.